Position in LLY
as of Jun 30, 2026
· filed Aug 11, 2026
Position Value
$3,881,355
+$746,779 QoQ
Shares Held
3,236
-5.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
1.71%
of 13F equity value
Holder Rank
#1,919
of 4,605 holders
Holding Since
Sep 2024
8 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in LLY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Altman Advisors, Inc. holds $13,882,576 across 5 Drug Manufacturers - General names. LLY ranks #1 (28.0% of the industry book) .
All Filings in LLY
Export CSV
8 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $3,881,355 | 3,236 | Shares | Sole | 2026-08-11 | |
| 2026-03-31 | $3,134,576 | 3,408 | Shares | Sole | 2026-05-05 | |
| 2025-12-31 | $3,618,447 | 3,367 | Shares | Sole | 2026-02-04 | |
| 2025-09-30 | $2,572,836 | 3,372 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $1,396,138 | 1,791 | Shares | Sole | 2025-08-07 | |
| 2025-03-31 | $1,421,391 | 1,721 | Shares | Sole | 2025-05-02 | |
| 2024-12-31 | $521,100 | 675 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $1,424,591 | 1,608 | Shares | Sole | 2024-11-08 | |
| No filing history on record for this holder in this stock. | ||||||